Lapatinib Recruiting Phase 2 Trials for Stage IV Breast Cancer / Her2-Positive Breast Cancer / Recurrent Breast Cancer Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01873833Capecitabine, Cyclophosphamide, Lapatinib Ditosylate, and Trastuzumab in Treating Patients With HER2-Positive Metastatic Breast Cancer